Genetic factors affecting thrombosis in patients with essential thrombocythemia by heparin treatment
Letter to the Editor
- 19 Downloads
Compliance with ethical standards
Conflict of interest
The author has no conflict of interest in this study.
- 1.Castelli R, Gallipoli P, Schiavon R, Teatini T, Deliliers GL, Bergamaschini L (2019) Increased risk of heparin induced thrombocytopenia and thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation. J Thromb Thrombolysis 47(1):155–156. https://doi.org/10.1007/s11239-018-1773-4 CrossRefGoogle Scholar
© Springer Science+Business Media, LLC, part of Springer Nature 2019